Frontier Medicines Raises $88.5 Million Series B Financing to Advance Precision Oncology and Targeted Protein Degradation Pipeline

Frontier Medicines Raises $88.5 Million Series B Financing to Advance Precision Oncology and Targeted Protein Degradation Pipeline

BEGIN Berkeley Gateway to Innovation
portal to the UC Berkeley entrepreneurship community

Join the IPIRA Mailing List

Read the IPIRA Newsletter

Accessibility | Nondiscrimination | Privacy

© 2022 Regents of the University of California. All Rights Reserved.